impact factor
logo
 

Full Papers

 

Overactive bladder syndrome and sexual dysfunction in women with fibromyalgia and their relationship with disease severity


1, 2, 3, 4, 5, 6

 

  1. Rheumatology Clinic, Ospedale Carlo Urbani, Università Politecnica delle Marche, Jesi, Ancona, Italy.
  2. Rheumatology Clinic, Ospedale Carlo Urbani, Università Politecnica delle Marche, Jesi, Ancona, Italy. dica.marco@yahoo.it
  3. Rheumatology Clinic, Ospedale Carlo Urbani, Università Politecnica delle Marche, Jesi, Ancona, Italy.
  4. Rheumatology Unit, Internal Medicine Department, ASST Fatebenefratelli-Sacco, Milan; University School of Medicine, Milan, Italy.
  5. Azienda Sanitaria Unica Regionale (ASUR) Marche, Area Vasta 2, Dipartimento Integrazione Ospedale-Territorio, Regione Marche, Italy.
  6. Rheumatology Unit, Internal Medicine Department, ASST Fatebenefratelli-Sacco, Milan; University School of Medicine, Milan, Italy.

CER14909
2022 Vol.40, N°6
PI 1091, PF 1101
Full Papers

Free to view
(click on article PDF icon to read the article)

PMID: 35200119 [PubMed]

Received: 17/06/2021
Accepted : 20/09/2021
In Press: 04/02/2022
Published: 22/06/2022

Abstract

OBJECTIVES:
The aim of this study was to evaluate the prevalence and severity of overactive bladder syndrome (OAB) and sexual dysfunction in fibromyalgia (FM) patients, as well as their relationship with disease severity.
METHODS:
Consecutive adult female patients with FM were enrolled. Patients filled in a comprehensive questionnaire package including demographic variables, disease severity assessment (revised Fibromyalgia Impact Questionnaire [FIQR]), neuropathic pain features (PainDetect Questionnaire [PDQ]), severity of OAB symptoms (Overactive Bladder Symptom Score [OABSS]), and determining sexual functioning (Female Sexual Function Index [FSFI]).
RESULTS:
The study included 481 patients, 116 (24.11%) had mild OAB, 82 patients (17.04%) had moderate OAB, and 34 patients had serious OAB (7.06%). In 14.17% of patients the bladder condition was causing them major issues in terms of discomfort. In 7.87% of patients the bladder condition was causing them significant problems. Sexual dysfunctions were found in 91 patients (18.91%). Using the FSFI as dependent variable, multivariate analysis revealed a positive relationship between sexual dysfunction and variables of disease burden (FIQR, p<0.0001; PDQ, p<0.0001, widespread pain index [WPI], p=0.0037). Using OABSS as the dependent variable, multivariate regression revealed a substantial contribution from FIQR (p<0.0001), PDQ (p=0.0037), and WPI (p=0.0030).
CONCLUSIONS:
FM has the potential to affect both psychological and physiological processes in women with OAB and sexual dysfunction. These results emphasize the importance of a multidisciplinary approach to treat patients with overactive bladder syndrome and sexual dysfunction in FM.

DOI: https://doi.org/10.55563/clinexprheumatol/9mbbpb

Rheumatology Article